{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15312359", "DateCompleted": {"Year": "2005", "Month": "02", "Day": "22"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "0253-3766", "JournalIssue": {"Volume": "26", "Issue": "5", "PubDate": {"Year": "2004", "Month": "May"}}, "Title": "Zhonghua zhong liu za zhi [Chinese journal of oncology]", "ISOAbbreviation": "Zhonghua Zhong Liu Za Zhi"}, "ArticleTitle": "[Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by beta-elemene].", "Pagination": {"StartPage": "268", "EndPage": "270", "MedlinePgn": "268-70"}, "Abstract": {"AbstractText": ["To study the reversal mechanism of adriamycin (ADM) resistance in human breast cancer cell line MCF-7/ADM by beta-elemene (beta-ELE), a wide spectrum anticancer drug derived from the Chinese herb Curcuma chaeocaulis.", "Sensitivity to ADM of MCF-7/ADM cells was studied by MTT assay. Intracellular accumulation of ADM in MCF-7/ADM cells was observed by fluorescent-spectrophotometry. Expression of bcl-2 protein was detected by flow cytometry.", "A non-cytotoxic dose (6 micro g/ml) and a weakly cytotoxic dose (13 micro g/ml) of beta-ELE could significantly enhance the cytotoxic effects of ADM on MCF-7/ADM cells to 1.4 and 2.2 fold as compared to the beta-ELE untreated control cells. The intracellular concentration of ADM in MCF-7/ADM cells was significantly increased after treatment with beta-ELE (P < 0.01). The expression of bcl-2 protein in MCF-7/ADM cells was reduced from 90.2% to 70.0% (P < 0.05).", "beta-ELE could partially reverse the drug resistance to ADM in MCF-7/ADM, which is related to the increased accumulation of intracellular ADM and the decreased expression of bcl-2."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Dalian Medical University, Dalian 116027, China."}], "Identifier": [], "LastName": "Hu", "ForeName": "Jun", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jin", "ForeName": "Wei", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yang", "ForeName": "Pei-man", "Initials": "PM"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhonghua Zhong Liu Za Zhi", "NlmUniqueID": "7910681", "ISSNLinking": "0253-3766"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "beta-elemene"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemistry"], "DescriptorName": "Curcuma"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Sesquiterpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "8", "Day": "18", "Hour": "5", "Minute": "0"}, {"Year": "2005", "Month": "2", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "8", "Day": "18", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15312359"]}}], "PubmedBookArticle": []}